Activist 13D/13G Filings - Canaan XI L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-01
4:30 pm
Sale
13GRALLYBIO CORP COM
RLYB
Canaan XI L.P.2,059,712
6.4%
-350,000decrease
(-14.52%)
View
2022-11-02
4:15 pm
Sale
13DDAY ONE BIOPHARMACEUTICALS INC
DAWN
Canaan XI L.P.2,548,403
3.5%
-2,200,000decrease
(-46.33%)
View
2022-10-19
5:29 pm
Sale
13DDAY ONE BIOPHARMACEUTICALS INC
DAWN
Canaan XI L.P.4,748,403
6.5%
-2,215,898decrease
(-31.82%)
View
2022-09-22
11:06 am
Sale
13DDAY ONE BIOPHARMACEUTICALS INC
DAWN
Canaan XI L.P.6,964,301
9.5%
-2,338,998decrease
(-25.14%)
View
2022-09-19
2:02 pm
Sale
13DDAY ONE BIOPHARMACEUTICALS INC
DAWN
Canaan XI L.P.9,303,299
12.7%
-360,346decrease
(-3.73%)
View
2022-02-08
3:28 pm
Purchase
13GTYRA BIOSCIENCES INC
TYRA
Canaan XI L.P.3,936,595
9.5%
3,936,595increase
(New Position)
View
2022-02-08
1:18 pm
Purchase
13GRALLYBIO CORP COM
RLYB
Canaan XI L.P.2,409,712
7.5%
2,409,712increase
(New Position)
View
2021-12-22
4:39 pm
Sale
13DDAY ONE BIOPHARMACEUTICALS INC
DAWN
Canaan XI L.P.9,663,645
15.6%
-1,072,000decrease
(-9.99%)
View
2021-12-20
4:50 pm
Sale
13DAEVA TECHNOLOGIES INC
AEVA
Canaan XI L.P.18,485,196
8.6%
-2,065,000decrease
(-10.05%)
View
2021-06-10
4:13 pm
Purchase
13DDAY ONE BIOPHARMACEUTICALS INC
DAWN
Canaan XI L.P.10,735,645
17.3%
10,735,645increase
(New Position)
View
2021-03-22
5:06 pm
Purchase
13DAEVA TECHNOLOGIES INC
AEVA
Canaan XI L.P.20,550,196
9.7%
20,550,196increase
(New Position)
View